# Market Access & HEOR hear the payer objection first.

Payer objections, value story, evidence — surface access risks before reimbursement.

**Atrix** Source-traceable Life-sciences-grade GxP-aware governance

## Outputs you can defend, ship, and act on.

### Capability 01
#### Stress-test value stories, HEOR evidence packages, and payer narratives against actual objections  
Grounded in your evidence, traceable to source, ready for review.

### Capability 02
#### Simulate national payer and HTA body responses to reimbursement submissions  
Grounded in your evidence, traceable to source, ready for review.

### Capability 03
#### Prioritize RWE endpoint design and evidence generation based on payer signal  
Grounded in your evidence, traceable to source, ready for review.

## From question to decision in one workflow.

### Worked example · Market Access & HEOR

#### Step 01
##### Bring your evidence  
Connect your internal data, ad boards, MSL notes, surveys, and field intel. Atrix ingests and structures it in days, not quarters.

#### Step 02
##### Ask the decision  
Frame the question — a launch message, payer story, KOL strategy, trial design, or AdCom prep — in plain language.

#### Step 03
##### Run, simulate, ship  
Get the read-out: themes, gaps, simulated responses, recommended actions — all source-traceable and review-ready.

> “We used to spend weeks synthesising what our teams already knew. Atrix gives us a decision-ready read in a day, with the receipts.
> 
> — Senior leader · global pharma

## Ready to use Atrix for market access & heor?

30 minutes. Your decision — a launch message, payer story, MSL talk track, competitor scenario. We'll show how Atrix runs it live.